Publications by authors named "A Gharaibeh"

Article Synopsis
  • Biologics and oral small molecules (OSM) are effective treatments for inflammatory bowel disease (IBD), but concern exists over their potential to increase risks of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE).
  • Using a multi-institutional database, the study matched IBD patients on biologics and OSM with similar patients not on these treatments to assess MACE and VTE risks from 30 days to 3 years post-prescription.
  • Results indicated that biologic-treated IBD patients had lower risks of MACE and VTE after 1 and 3 years, while OSM users showed reduced all-cause mortality but no significant difference in MACE or VTE risks, suggesting
View Article and Find Full Text PDF

Background: The impact of COVID-19 on pregnancy remains a critical area of research, with growing evidence suggesting that maternal infection, particularly in the third trimester, may lead to significant complications Aims: The primary aim was to investigate the maternal and neonatal outcome of pregnant Jordanian women with COVID-19. The secondary aim included exploring demographics, obstetrics characteristics, and comorbidities among these women.

Methods: A retrospective comprehensive review of the records of 300 cases of pregnant women with COVID-19, who were treated between November 2020 and April 2021 at Queen Alia Military Hospital (a main referral center for patients with COVID-19) in Jordan.

View Article and Find Full Text PDF

Aims: Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI-related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI-related adverse events. Additionally, whether incident irM portends worse long-term CV outcomes remains unclear.

View Article and Find Full Text PDF

Fibrinolytic and coagulative hyperactivity is proven to have a role in liquefaction and progression of chronic subdural hematoma (CSDH). Tranexamic acid was one of the pharmaceutical options that was explored, as it inhibits the hyper-fibrinolytic activity and reduces the vascular permeability in CSDH, leading to a gradual resolution of the hematoma. In this case study, we present a case of using tranexamic acid for CSDH treatment in an 86-year-old patient with co-morbidities.

View Article and Find Full Text PDF

: The COVID-19 pandemic has had a significant global impact, necessitating a comprehensive understanding of its spatiotemporal patterns. The objective of this study is to explore the spatial and temporal patterns of COVID-19 infections among five age groups (<1, 1-4, 5-9, 10-14, and 15-19 years) in 72 districts of Slovakia on a quarterly basis from March 2020 to July 2022. : During the study period, a total of 393,429 confirmed PCR cases of COVID-19 or positive antigen tests were recorded across all studied age groups.

View Article and Find Full Text PDF